Eli Lilly misses revenue forecast
April 24, 2014 at 06:43 AM EDT
April 24 (Reuters) - U.S. drugmaker Eli Lilly and Co on Thursday reported lower than expected revenue, hurt by plunging sales of its Cymbalta depression drug, which is now facing generic competition.